Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Mok (Perth, WA, Australia). Examining the effects of the Gly551Asp mutation on CT outcomes in children with cystic fibrosis. 1830

Member's Comments

No comment yet.

Related content which might interest you: The effect of CFTR modulators on CT outcomes in cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 High morbidity and mortality in cystic fibrosis patients compound heterozygous for 3905insT and ΔF508 Source: Eur Respir J 2001; 17: 1181-1186 Year: 2001 Forecasting US ivacaftor outcomes and cost in cystic fibrosis patients with the G551D mutation Source: Eur Respir J 2016; 47:1697-1705 Year: 2016 Should the D1152H variant be included in cystic fibrosis newborn screening programmes? Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020 Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients Source: Eur Respir J 2004; 23: 679-684 Year: 2004 Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population Source: Eur Respir J, 56 (3) 2000558; 10.1183/13993003.00558-2020 Year: 2020 A novel CFTR mutation found in a Chinese cystic fibrosis patient Source: Eur Respir J 2005; 26: Suppl. 49, 402s Year: 2005 Distinctive CFTR gene mutations found in Japanese individuals with cystic fibrosis Source: Annual Congress 2004 - Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems Year: 2004 Long-term outcomes and clinical worsening in cystic fibrosis patients with at least one residual function mutation Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 Progression of lung disease detected by MRI and impact of NBS in preschool children with cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 CFTR gene mutations detected in Japanese individuals with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 716s Year: 2006 Characteristics of cystic fibrosis patients diagnosed after false negative cystic fibrosis newborn screening results Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019 The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 Polysomnograpgic findings in children with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 391s Year: 2003 Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease Source: Eur Respir Rev, 29 (155) 190112; 10.1183/16000617.0112-2019 Year: 2020 Potentiating and correcting mutant CFTR in patients with cystic fibrosis Source: Eur Respir Monogr 2014; 64: 129-149 Year: 2014 Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles Source: ERJ Open Res, 5 (2) 00082-2019; 10.1183/23120541.00082-2019 Year: 2019 First identified “severe” mutations and extended rearrangements in the CFTR gene in Russian cystic fibrosis patients Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020 Real life experience of lumacaftor/ivacafotor in adult Phe508del homozygous cystic fibrosis patients. Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018